Adcentrx Announces FDA Clearance For ADRX-0405 ADC For Tumors
21 Oct 2024 //
PR NEWSWIRE
Adcentrx Therapeutics gains China NMPA clearance for ADRX-0706.
06 May 2024 //
PR NEWSWIRE
AbbVie files trade secrets suit against Adcentrx and former employee
21 Dec 2023 //
ENDPTS
Adcentrx, AvantGen ink 3Y partnership for Abs for novel Ab-drug conjugates
16 Feb 2022 //
PHARMABIZ